SNW(SH:600628)2025-10-30 08:00Financial Performance - Total revenue for Q3 2025 was CNY 263,403,980.88, a decrease of 1.13% compared to the same period last year[5] - Net profit attributable to shareholders was CNY 19,009,552.75, reflecting a slight increase of 0.60% year-on-year[5] - The net profit after deducting non-recurring gains and losses decreased by 17.66% to CNY 13,256,996.68[5] - Total operating revenue for the first three quarters of 2025 was CNY 791,459,183.99, a decrease of 1.6% compared to CNY 806,810,686.48 in the same period of 2024[14] - Net profit for the first three quarters of 2025 was CNY 64,280,826.93, slightly down from CNY 64,790,469.22 in 2024, indicating stable profitability[14] - Operating profit for the first three quarters of 2025 was CNY 67,426,730.23, compared to CNY 78,895,531.88 in 2024, reflecting a need for operational efficiency improvements[14] - The company’s other comprehensive income showed a loss of CNY 1,405,833.24, contrasting with a gain of CNY 1,144,046.00 in the previous year, highlighting volatility in financial performance[14] - Basic and diluted earnings per share remained stable at CNY 0.10 for both 2025 and 2024, reflecting consistent earnings performance[14] Assets and Liabilities - Total assets at the end of the reporting period were CNY 5,667,256,799.50, down 1.23% from the end of the previous year[5] - The company reported a total liability of CNY 1,419,341,371.02, a decrease from CNY 1,526,214,457.61 in the previous year, showing improved financial health[13] - The total equity attributable to shareholders increased to CNY 4,247,324,000.77 from CNY 4,210,310,649.49, indicating growth in shareholder value[13] - The total liabilities and equity amounted to CNY 5,667,256,799.50, down from CNY 5,738,064,887.48, indicating a reduction in overall financial obligations[13] Cash Flow - Cash flow from operating activities for the year-to-date was CNY 92,977,844.61, a decrease of 19.79% compared to the same period last year[5] - In the first three quarters of 2025, the net cash flow from operating activities was ¥92,977,844.61, a decrease of 20% compared to ¥115,913,453.14 in the same period of 2024[16] - Total cash inflow from operating activities was ¥1,025,706,577.39, down from ¥1,085,072,874.60 in 2024, reflecting a decline of approximately 5.5%[16] - Cash outflow from operating activities totaled ¥932,728,732.78, compared to ¥969,159,421.46 in 2024, indicating a reduction of about 3.7%[16] - Cash inflow from investment activities reached ¥3,017,963,810.30, an increase from ¥2,908,079,968.64 in 2024, representing a growth of approximately 3.8%[16] - The net cash flow from investment activities was ¥61,697,609.02, significantly lower than ¥242,593,506.69 in the previous year, marking a decline of about 74.5%[16] - Cash inflow from financing activities was ¥477,500,000.00, down from ¥656,250,000.00 in 2024, reflecting a decrease of approximately 27.3%[16] - The net cash flow from financing activities was -¥59,855,852.55, compared to -¥38,286,703.33 in 2024, indicating a worsening of about 56.5%[16] - The ending balance of cash and cash equivalents was ¥1,454,105,853.09, slightly up from ¥1,442,519,035.37 in 2024[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 43,175[10] - The largest shareholder, Shanghai Huangpu District State-owned Assets Supervision and Administration Commission, holds 20.73% of shares, totaling 134,074,446 shares[10] - The company has a total of 10 major shareholders, with the top three holding a combined 41.47% of shares[10] - The company has not reported any significant changes in shareholder participation in margin trading or securities lending[10] Investment and Construction - The company reported a significant increase of 454.77% in non-operating income due to higher government subsidies compared to the previous year[9] - The company experienced a 100% increase in asset disposal income due to auction income from scrapped assets[9] - The company noted a 71.07% increase in construction in progress due to the expansion of its traditional Chinese medicine production base[7] Current Assets - The company's total current assets as of September 30, 2025, amount to ¥2,344,718,706.66, a decrease from ¥2,408,366,340.26 at the end of 2024[12] - Cash and cash equivalents increased to ¥1,486,093,955.54 from ¥1,378,780,862.67 year-over-year[12] - The company's total assets as of September 30, 2025, are ¥5,667,256,799.50, down from ¥5,738,064,887.48 at the end of 2024[12] - The inventory decreased to ¥160,066,182.17 from ¥195,495,351.20 year-over-year[12] - The long-term equity investment remains stable at ¥23,066,279.33[12] - The total non-current assets as of September 30, 2025, are ¥3,322,538,092.84, slightly down from ¥3,329,698,547.22 at the end of 2024[12]